Adenocarcinoma of the Esophagus Completed Phase 2 Trials for IT-101 (DB05899)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01612546Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by SurgeryTreatment